• Mashup Score: 0

    September 25, 2023 —  After world’s first successful transplant in 2022, also performed at the University of Maryland Medical Center (UMMC), this groundbreaking transplant team performed second pig heart transplant on patient deemed ineligible for traditional heart transplant.  A 58-year-old patient with terminal heart disease became the second patient in the world to receive a historic transplant of a genetically-modified pig heart on September 20. He is recovering and communicating with his loved ones. This is only the second time in the world that a genetically modified pig heart has been transplanted into a living patient.  Both historic surgeries were performed by University of Maryland School of Medicine (UMSOM) faculty at the University of Maryland Medical Center (UMMC).  The first historic surgery, performed in January, 2022, was conducted on David Bennett by University of Maryland Medicine surgeons (comprising UMSOM and UMMC), who are recognized as the leaders in cardiac xenot

    Tweet Tweets with this article
    • @DAICeditor @UMmedschool Landmark #cardiac #xenotransplantation procedure conducted at University of Maryland Medical Center: https://t.co/cXPNjKy2Cp #pigheart @artificialheart #transplant

  • Mashup Score: 0

    September 19, 2023 — A mathematical and computational model of the human heart entirely developed at Politecnico di Milano and designed for studying coronary artery disease. This is the focus of research published in the prestigious journal Nature Scientific Reports, entitled ‘A comprehensive mathematical model for cardiac perfusion’. The project was born from collaboration between the MOX lab of the Department of Mathematics and the LaBS of the Department of Chemistry, Materials and Chemical Engineering ‘Giulio Natta’ of Politecnico di Milano, and now presents the results of the iHEART Simulator.  What makes iHEART Simulator unique is its ability to combine the complex processes of electromechanics, haemodynamics and cardiac perfusion into a single platform. This level of integration offers unprecedented biophysical accuracy in the simulation of heart function and related diseases.  One of the most innovative aspects of this study is the application of this model to the analysis of co

    Tweet Tweets with this article
    • @DAICeditor The results of the #iHEART project have been published in the prestigious journal #NatureScientificReports. The project has also developed mathematical models to understand #cardiac #arrhythmias: https://t.co/df0lHyDQBg

  • Mashup Score: 0

    September 7, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced that it has signed an exclusive agreement with University of California, San Francisco (UCSF) to commercialize three AI algorithms for the automated detection of cardiovascular diseases. Developed at UCSF by leading researchers, these AI algorithms to detect cardiac amyloidosis, pulmonary hypertension, and supraventricular tachycardia are based on analysis of electrocardiograms (ECGs), the most widely used diagnostic test for characterization of cardiac structure and electrical activity of the heart.  “We are enthusiastic about the possibility of applying these AI-powered algorithms in clinical practice to enable knowledge and discovery, and to provide timely insights for decision-making,” said Anthony Francis, executive director of the Office of Technology Management and Advancement from the University. ”These algorithms improve on existing systems and meet or exceed clini

    Tweet Tweets with this article
    • @DAICeditor @UCSFHospitals Exclusive agreement for AI algorithms to accelerate earlier detection of #cardiac #amyloidosis and #pulmonary #hypertension: https://t.co/rlPNCZuM64

  • Mashup Score: 4

    Catholic Health and NewYork-Presbyterian, two leading health care systems serving the New York metropolitan area, announced they have signed a clinical collaboration agreement to provide an unparalleled level of cardiac care in Long Island. Together, the health care systems will advance best-in-class cardiovascular care on Long Island.  The collaboration will initially focus on expanding St. Francis Hospital & Heart Center®’s advanced heart failure, adult congenital heart disease and pediatric cardiology programs, while also extending NewYork-Presbyterian’s leading heart transplant program to Long Island, where patients can access the very best pre-and post-transplant continuum of care at St. Francis Hospital & Heart Center®. “Catholic Health and St. Francis have each earned a national reputation for excellence in cardiovascular care across a number of sub-specialties,” said Dr. Patrick O’Shaughnessy, president and chief executive officer of Catholic Health. “This unique collaboration

    Tweet Tweets with this article
    • Looking forward to further advancing the #cardiac care of our #LongIsland patients through this innovative collaboration between my old home (@nyphospital ) and new home (@StFrancis_LI @CHS_LI ) #LongLiveLongIsland https://t.co/ZcNVjStioR https://t.co/kLTspobj5J